Acorda Therapeutics, Inc. Severance Costs
Acorda Therapeutics, Inc. reported Severance Costs of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2024-04-01
- Acorda Therapeutics, Inc. severance costs for the quarter ending 2017-12-31 was $0.00.
- Acorda Therapeutics, Inc. severance costs for the quarter ending 2017-09-30 was $30.00K.
- Acorda Therapeutics, Inc. severance costs for the quarter ending 2017-06-30 was $7.60M.
- Acorda Therapeutics, Inc. severance costs for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Acorda Therapeutics, Inc. severance costs for fiscal 2022 was $300.00K, a 95.00% decline from fiscal 2021.
- Acorda Therapeutics, Inc. severance costs for fiscal 2021 was $6.00M, a 1900.00% increase from fiscal 2020.
- Acorda Therapeutics, Inc. severance costs for fiscal 2020 was $300.00K, a 93.18% decline from fiscal 2019.
| Period end | Severance Costs 3 month | Severance Costs 6 month | Severance Costs 9 month | Severance Costs 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-04-01 | |||
| 2022-12-31 | $300.00K 10-K · filed 2024-04-01 | |||
| 2021-12-31 | $6.00M 10-K · filed 2023-03-15 | |||
| 2020-12-31 | $300.00K 10-K · filed 2022-03-18 | |||
| 2019-12-31 | $4.40M 10-K · filed 2021-03-16 | |||
| 2018-12-31 | $1.30M 10-K · filed 2020-02-28 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $30.00K derived: sum of 2 quarters · filed 2020-02-28 | $7.63M derived: sum of 3 quarters · filed 2020-02-28 | $7.60M 10-K · filed 2020-02-28 |
| 2017-09-30 | $30.00K 10-Q · filed 2017-11-07 | $7.63M derived: sum of 2 quarters · filed 2017-11-07 | $7.60M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $7.60M 10-Q · filed 2017-08-08 | $7.60M 10-Q · filed 2017-08-08 |